Viferon ointment is a means of preventing influenza and treating skin infections. Viferon - the main assistant to the immunity of newborns in the fight against viruses Viferon gel up to the back of the maximum number of days

The drug is used externally and topically.

In the complex therapy of acute respiratory viral infections, including influenza, long-term and frequent acute respiratory viral infections, including those complicated by a bacterial infection: a strip of gel no longer than 0.5 cm is applied to the previously dried surface of the nasal mucosa and / or to the surface of the palatine tonsils 3-5 times a day with a spatula or cotton swab/cotton swab (see note). The course of treatment is 5 days, if necessary, the course can be extended.

Prevention of acute respiratory viral infections, including influenza: during the period of rising incidence, a strip of gel no longer than 0.5 cm is applied to the previously dried surface of the nasal mucosa and / or to the surface of the palatine tonsils 2 times a day for 2-4 weeks.

In the complex therapy of recurrent stenosing laryngotracheobronchitis: a strip of gel no longer than 0.5 cm is applied to the surface of the palatine tonsils with a spatula or cotton swab / cotton swab in the acute period of the disease 5 times a day, for 5-7 days, then 3 times a day. day for the next 3 weeks.

Prevention of recurrent stenosing laryngotracheobronchitis: a strip of gel no longer than 0.5 cm is applied to the surface of the palatine tonsils with a spatula or cotton swab / cotton swab 2 times a day for 3-4 weeks, courses are repeated 2 times a year.

In the complex therapy of acute and chronic recurrent herpetic infection (when the first signs of the disease appear or during the period of precursors): a strip of gel no longer than 0.5 cm is applied
using a spatula or a cotton swab / cotton swab on a previously dried affected surface 3-5 times a day for 5-6 days, if necessary, the duration of the course is increased until the clinical manifestations disappear.

In the complex therapy of herpetic cervicitis: 1 ml of the gel is applied with a cotton swab to the surface of the cervix previously cleared of mucus 2 times a day for 7 days, if necessary, the duration of the course can be increased to 14 days.

Note. The gel is applied to the mucous membrane of the nasal cavity after cleansing the nasal passages, to the surface of the palatine tonsils - 30 minutes after eating. When applying the gel to the palatine tonsils, do not touch the tonsils with a cotton swab, but only with a gel, while the gel independently flows down the surface of the tonsil. When applying the gel to the cervix, you should first remove the mucus and discharge from the vaginal and cervix with a cotton or gauze swab.

When applying the gel to the affected areas of the skin and mucous membranes, a thin film is formed after 30-40 minutes, on which the drug is again applied. If desired, the film can be peeled off or washed off with water before re-applying the drug. The opened tube is stored in the refrigerator for no more than 2 months. A drug with a broken package integrity and a changed color is not suitable for use.

Active substance

Interferon alpha-2b human recombinant (interferon alfa-2b)

Release form, composition and packaging

◊ Gel for external and topical use in the form of a homogeneous, opaque, gel-like mass of white color with a grayish tint.

Excipients: α-tocopherol acetate - 55 mg, benzoic acid - 1.28 mg, decahydrate - 1.8 mg, methionine - 1.2 mg, citric acid monohydrate - 1 mg, sodium chloride - 4 mg, human serum albumin solution 10% - 20 mg, glycerol (distilled) - 20 mg, carmellose sodium - 20 mg, ethanol 95% - 55 mg, purified water - up to 1 g.

12 g - aluminum tubes (1) - packs of cardboard.

pharmachologic effect

Interferon alpha-2b human recombinant has immunomodulatory and antiproliferative properties. Suppresses the replication of RNA and DNA-containing viruses. The immunomodulatory properties of interferon, such as increased phagocytic activity of macrophages, increased specific cytotoxicity of lymphocytes to target cells, determine its mediated antibacterial activity.

In the presence of antioxidants, citric and benzoic acids, the specific antiviral activity of interferon increases, its immunomodulatory effect increases, which makes it possible to increase the efficiency of the body's own immune response to infectious agents.

The drug has a pronounced local immunomodulatory effect and contributes to an increase in locally formed antibodies of the secretory IgA class, which prevent the fixation and reproduction of pathogenic microorganisms on the mucous membranes, which provides a preventive effect of the drug for the prevention of viral and other diseases.

The gel base provides a prolonged effect of the drug. The antioxidants included in the dosage form - alpha-tocopherol acetate, citric and benzoic acids, have anti-inflammatory, membrane-stabilizing, regenerating properties, and also help to preserve the biological activity of human recombinant interferon alpha-2b.

Indications

- as part of the complex therapy of acute respiratory viral infections, incl. , frequent and prolonged SARS, incl. complicated by bacterial infection;

- prevention of acute respiratory viral infections, including influenza;

- as part of complex therapy for recurrent stenosing laryngotracheobronchitis;

- prevention of recurrent stenosing laryngotracheobronchitis;

- as part of the complex therapy of acute and exacerbations of chronic recurrent herpes infection of the skin and mucous membranes, incl. urogenital form of herpetic infection;

- as part of the complex therapy of herpetic cervicitis.

Contraindications

- Hypersensitivity to the components of the drug.

Dosage

The drug is used externally and topically.

As part of the complex therapy of acute respiratory viral infections, including influenza, long-term and frequent acute respiratory viral infections, incl. complicated by bacterial infection: a strip of gel no longer than 0.5 cm is applied to the previously dried surface of the nasal mucosa and / or to the surface of the palatine tonsils 3-5 times / day using a spatula or cotton swab / cotton swab. The course of treatment is 5 days, if necessary, the course can be extended.

Prevention of SARS, including influenza: during the period of rising incidence, a strip of gel no longer than 0.5 cm is applied to the previously dried surface of the nasal mucosa and / or to the surface of the palatine tonsils 2 times / day for 2-4 weeks.

As part of the complex therapy of recurrent stenosing laryngotracheobronchitis: a strip of gel no longer than 0.5 cm is applied to the surface of the palatine tonsils with a spatula or cotton swab / cotton swab in the acute period of the disease 5 times / day, for 5-7 days, then 3 times / day for the next 3 weeks.

Prevention of recurrent stenosing laryngotracheobronchitis: a strip of gel no longer than 0.5 cm is applied to the surface of the palatine tonsils with a spatula or cotton swab / cotton swab 2 times / day for 3-4 weeks, courses are repeated 2 times a year.

As part of complex therapy for acute and chronic recurrent herpes infection(when the first signs of the disease appear or during the period of precursors): a strip of gel no longer than 0.5 cm is applied with a spatula or a cotton swab / cotton swab on a previously dried affected surface 3-5 times / day for 5-6 days, if necessary, the duration the course is increased until the disappearance of clinical manifestations.

As part of the complex therapy of herpetic cervicitis: 1 ml of gel is applied with a cotton swab to the surface of the cervix, previously cleared of mucus, 2 times / day for 7 days, if necessary, the duration of the course can be increased to 14 days.

Rules for using the gel

The gel is applied to the mucous membrane of the nasal cavity after cleansing the nasal passages, to the surface of the palatine tonsils - 30 minutes after eating.

When applying the gel to the palatine tonsils, do not touch the tonsils with a cotton swab, but only with a gel, while the gel independently flows down the surface of the tonsil.

When applying the gel to the cervix, you should first remove the mucus and discharge from the vaginal and cervix with a cotton or gauze swab.

Side effects

Allergic reactions: very rarely - skin rashes, itching.

Overdose

Data on drug overdose are not provided.

Instructions for use:

Viferon is an immunomodulatory, antiproliferative and antiviral drug.

Release form and composition

Viferon is produced in the form:

Ointment for local and external use - homogeneous, viscous, yellowish-white or yellow, with a specific smell of lanolin (6 g or 12 g in aluminum tubes, 12 g in polystyrene jars, 1 tube or jar in a cardboard box);
Gel for local and external use - gel-like, opaque, homogeneous white mass with a grayish tint (12 g in aluminum tubes or in polystyrene jars, 1 tube or jar in a cardboard box);
Suppositories for rectal use - bullet-shaped, uniform consistency, white with a yellowish tint, with a diameter of up to 10 mm (10 pcs in blister packs, 1 or 2 packs in a carton box).

The composition of 1 g of ointment includes:

Active substance: human recombinant interferon alpha-2b - 40,000 International units (IU);
Auxiliary components: anhydrous lanolin - 0.34 g; tocopherol acetate - 0.02 g; peach oil - 0.12 g; medical vaseline - 0.45 g; purified water - up to 1 g.

The composition of 1 g of gel includes:

Active substance: human recombinant interferon alpha-2b - 36000 IU;
Auxiliary components: 95% ethanol - 0.055 g; alpha-tocopherol acetate - 0.055 g; methionine - 0.0012 g; benzoic acid - 0.00128 mg; citric acid monohydrate - 0.001 g; sodium chloride - 0.004 g; sodium tetraborate decahydrate - 0.0018 mg; distilled glycerin (glycerol) - 0.02 g; 10% solution of human serum albumin - 0.02 g; carmellose sodium - 0.02 g; purified water - up to 1 g.

The composition of 1 suppository includes:

Active substance: human recombinant interferon alpha-2b - 150,000, 500,000, 1,000,000 or 3,000,000 IU;
Auxiliary components: ascorbic acid - 0.0054 / 0.0081 / 0.0081 / 0.0081 g, respectively; alpha-tocopherol acetate - 0.055 g each; disodium edetate dihydrate - 0.0001 g each; sodium ascorbate - 0.0108 / 0.0162 / 0.0162 / 0.0162 g, respectively; polysorbate 80 - 0.0001 g each;
Base: confectionery fat and cocoa butter - up to 1 g.

Indications for use

Viferon in the form of an ointment is prescribed for the treatment of the following diseases:

Acute respiratory viral infections (ARVI) and influenza in children older than 1 year;
Viral (including herpetic) lesions of the mucous membranes and skin of various localization.

The drug in the form of a gel is indicated for use:

SARS, including influenza, long-term and frequent SARS, incl. bacterial infections occurring with complications (prophylaxis, simultaneously with other drugs);
Recurrent stenosing laryngotracheobronchitis (prevention, simultaneously with other drugs);
Herpetic cervicitis (simultaneously with other drugs);
Herpetic infection of mucous membranes and skin (acute and exacerbations of chronic recurrent), incl. urogenital form of herpetic infection (simultaneously with other drugs).

Viferon in the form of suppositories is used simultaneously with other drugs in the treatment of diseases:

SARS, including influenza, incl. occurring with complications of bacterial infections, pneumonia (chlamydial, viral, bacterial) in adults and children;
Chronic viral hepatitis B, C, D in adults and children, incl. in combination with the use of hemosorption and plasmapheresis in chronic viral hepatitis of severe activity, which are complicated by cirrhosis of the liver;
Infectious and inflammatory diseases in newborns (including premature babies): sepsis, meningitis (viral, bacterial), intrauterine infection (enterovirus infection, chlamydia, CMV infection, herpes, mycoplasmosis, candidiasis, including visceral);
Recurrent or primary herpetic infection of the mucous membranes and skin, localized form, moderate and mild course, including the urogenital form in adults;
Infectious and inflammatory diseases of the urogenital tract (bacterial vaginosis, ureaplasmosis, chlamydia, papillomavirus infection, CMV infection, gardnerellosis, trichomoniasis, mycoplasmosis, recurrent vaginal candidiasis) in adults.

Contraindications

Hypersensitivity to the components of the drug.

Method of application and dosage

Viferon ointment is used topically and externally.

Herpetic infection: the ointment should be applied 3-4 times a day with a thin layer on the lesions and gently rubbed. The duration of therapy is from 5 to 7 days. Treatment is recommended to start when the first signs of the disease appear (redness, burning, itching). With recurrent herpes, it is advisable to start treatment in the prodromal period or when the first signs of relapse appear.

Influenza and other SARS: the ointment is applied in a thin layer to the mucous membrane of the nasal passages 3-4 times a day during the entire period of the disease. Multiplicity of use for children 1-2 years old - 3 times a day, 2-12 years old - 4 times a day.

Viferon gel is used topically and externally.

Complex therapy of SARS: gel (a strip up to 5 mm long) should be applied to the surface of the nasal mucosa, which must be dried beforehand, and / or to the surface of the palatine tonsils, using a spatula or cotton swab, 3-5 times a day. The duration of the treatment course is 5 days, if necessary, therapy can be continued. For the prevention of acute respiratory viral infections during the rise in incidence, a strip of gel up to 5 mm is applied 2 times a day. The duration of Viferon application is 14-28 days.

Complex therapy of recurrent stenosing laryngotracheobronchitis: a strip of gel up to 5 mm long should be applied to the surface of the palatine tonsils. In the acute period of the disease (the first 5-7 days) - 5 times a day, then for 21 days - 3 times a day. To prevent the disease, the gel is used for 21-28 days 2 times a day, courses are recommended to be repeated 2 times a year.

Complex therapy of acute and chronic recurrent herpetic infection (when the first signs of the disease occur): a strip of gel up to 5 mm should be applied with a cotton swab / cotton swab or spatula to the affected surface, previously dried, 3-5 times a day for 5-6 days. The duration of the course can be increased until the disappearance of clinical manifestations.

Complex therapy of herpetic cervicitis: 1 ml of gel with a cotton swab should be applied 2 times a day to the surface of the cervix, which must first be cleared of mucus. The duration of the drug is 7-14 days.

The gel should be applied to the surface of the palatine tonsils half an hour after eating, on the mucous membrane of the nasal cavity - after cleaning the nasal passages. When Viferon is applied to the affected areas of the mucous membranes and skin for 30-40 minutes, a thin film is formed, on which the next dose is subsequently applied. If desired, the film can be washed off with water or peeled off.

Suppositories Viferon are used rectally.

Complex therapy of acute respiratory viral infections:

Adults and children from 7 years old - daily for 5 days (possibly longer according to indications). 2 times a day with a break of 12 hours, 1 suppository 500,000 IU;
Children under 7 years old, including newborns and premature babies with a gestational age of 34 weeks - daily, 1 suppository of 150,000 IU 2 times a day with an interval of 12 hours for 5 days (according to indications, treatment can be continued with a break of 5 days);
Premature newborns with a gestational age of up to 34 weeks - daily 1 suppository of 150,000 IU, 3 times a day with an interval of 8 hours for 5 days (according to indications, treatment can be continued with a break of 5 days).

Complex therapy of infectious and inflammatory diseases (sepsis, meningitis, intrauterine infections, including CMV infection, chlamydia, herpes, candidiasis, enterovirus infection) of newborns, incl. premature, with gestational age: older than 34 weeks - daily 1 suppository 150,000 IU 2 times a day with an interval of 12 hours, up to 34 weeks - daily 1 suppository 150,000 IU 3 times a day with an interval of 8 hours. Treatment course - 5 days.

Sepsis - 2-3 courses;
CMV infection - 2-3 courses;
Herpetic infection - 2 courses;
Meningitis - 1-2 courses;
Mycoplasmosis, candidiasis, incl. visceral - 2-3 courses;
Enterovirus infection - 1-2 courses.

In the presence of clinical indications, treatment can be continued.

Complex therapy of chronic viral hepatitis B, C, D: 10 days Viferon is used daily 2 times a day after 12 hours, then 6-12 months - 3 times a week every other day. The duration of therapy is determined by laboratory parameters and clinical efficacy. The daily dose is:

Adults - 2 suppositories of 3,000,000 IU;
Children from 7 years old - 5,000,000 IU per 1 m2 of body surface area;
Children 1-7 years old - 3,000,000 IU per 1 m2 of body surface area;
Children 6-12 months - 500,000 IU;
Children under 6 months - 300,000-500,000 IU.

Chronic viral hepatitis of severe activity and cirrhosis of the liver: before hemosorption and / or plasmapheresis, children under 7 years old are recommended to use Viferon daily at 150,000 IU, children over 7 years old - 500,000 IU 2 times a day with a break of 12 hours for 14 days.

Complex therapy of infectious and inflammatory diseases of the urogenital tract (mycoplasmosis, ureaplasmosis, papillomavirus infection, chlamydia, CMV infection, bacterial vaginosis, trichomoniasis, recurrent vaginal candidiasis, bacterial vaginosis): adults - 5-10 days daily, 1 suppository of Viferon 500,000 IU. Multiplicity of application - 2 times a day (every 12 hours). In the presence of clinical indications, treatment can be continued. According to the same scheme, in the first 10 days of treatment, Viferon is prescribed to pregnant women after 14 weeks of gestation. In the next 10 days, the drug is prescribed 1 suppository 2 times a day with a break of 12 hours every 4th day. Further - every 28 days until delivery, 1 suppository 150,000 IU 2 times a day with the same interval daily for 5 days. If necessary, before delivery (from 38 weeks of gestation) for 10 days appoint 1 suppository 500,000 IU 2 times a day.

Recurrent or primary herpetic infection of the skin and mucous membranes, localized form (moderate and mild course): the recommended single dose for adults for 10 days is 1,000,000 IU, for pregnant women from the 2nd trimester - 500,000 IU. The drug is used daily 2 times a day (every 12 hours). In the presence of clinical indications, therapy can be continued. In the future, Viferon can be used for pregnant women according to the treatment regimen for infectious and inflammatory diseases of the urogenital tract.

Side effects

Viferon in the form of an ointment is in most cases well tolerated. Side effects when applied to the nasal mucosa are usually transient and mild and disappear on their own after discontinuation of the drug.

In extremely rare cases, when using the gel in patients with hypersensitivity, local allergic reactions may develop. When they appear, treatment is stopped.

When using Viferon suppositories, in some cases, the development of allergic reactions (itching, skin rashes) is possible. These phenomena are reversible and disappear 72 hours after cessation of therapy.

special instructions

An opened tube with ointment can be stored in the refrigerator for 1 month, with a gel - 2 months.

Viferon in the form of suppositories for pregnant women can be used starting from the 14th week of pregnancy.

drug interaction

Viferon goes well with all drugs used in the treatment of viral and other diseases (chemotherapeutic agents, antibiotics, glucocorticosteroids).

Analogues

Analogues of Viferon are: Infagel, Vitaferon, Genferon, Laferon, Laferobion, Anaferon, Kipferon, Grippferon.

Terms and conditions of storage

Store in a dark, dry place out of the reach of children at a temperature of 2-8 °C.

The shelf life of the drug in the form of a gel and ointment is 1 year, suppositories - 2 years.

Viferon is a fairly popular drug used in childhood for the prevention of various viral infections, as well as in their treatment. The most common dosage form of Viferon is rectal suppositories. They are in demand because they are safe and can be used in newborns even with prematurity. However, Viferon is also produced in the form of a gel.

Features of the gel as a release form

Viferon gel is available in an aluminum tube containing 12 grams of medication.
Inside the tube is an opaque homogeneous mass. The gel has a white color, which may have a gray tint.
The gel, like other forms of Viferon, has an antiviral effect, and also has an immunomodulatory effect. It enhances the local production of antibodies and prevents the reproduction of pathogens.
1 gram of gel contains 36,000 IU of the main active substance represented by interferon alpha-2B (recombinant).
Additional substances are α-tocopherol acetate, serum albumin solution, citric acid, water, 95% ethanol, sodium chloride, glycerol, benzoic acid and other compounds.
Interferon from Viferon gel is poorly absorbed by the skin and does not have a systemic effect on the body, limited only by local effects.
Thanks to the gel base, the effect of the drug is prolonged, because 30-40 minutes after the treatment of the skin or mucous membrane, a thin film appears on it. It is not required to wash it off or exfoliate before the next application of a portion of the gel.
The drug rarely causes side effects in the form of an allergic reaction.
Store Viferon gel in a refrigerator for up to one year. If the tube is opened, its shelf life is reduced to two months.

Indications

SARS.
Flu.
Bacterial complications of SARS.
Stenosing laryngotracheitis.
Infection of the mucous or skin with the herpes virus.

Instructions for use

Viferon gel should be used externally:

In case of SARS or influenza, the nasal passages are cleaned, and the nasal mucosa is preliminarily dried, after which a gel is applied to it with a strip of up to 5 mm. The treatment is carried out for five days 3-5 times a day, and if necessary, the treatment is extended.
In the acute period of stenosing laryngotracheitis, a gel in the form of a strip up to 5 mm long is applied to the palatine tonsils half an hour after meals five times a day for 5-7 days. For application, a cotton swab is used, trying to prevent its contact with the tonsils (only the gel should come into contact with them). When the acute period passes, the frequency of treatment is reduced to 3 times a day, and treatment is continued for up to 3 weeks.
When infected with herpes, gel treatment begins with the first signs of virus activation. Using a cotton swab or spatula, a strip of the drug up to 5 mm long is applied to the dried infected surface. Treatment is performed 3 to 5 times daily for 5-6 days or longer.
For the prevention of influenza and SARS during the morbidity season, the palatine tonsils or nasal mucosa are treated twice a day. The surface is dried, and then smeared with a strip of the preparation up to 5 mm long. You can apply the product within two to four weeks.
To prevent recurrence of stenosing laryngotracheitis, the tonsils are treated with a gel twice a day, using a cotton swab or spatula. Such a course lasting three to four weeks is held twice a year.

Features of use in infants up to a year

Unlike ointment, this form of Viferon, like rectal suppositories, can be used in the first year of life. In this case, the indications and dosage of the drug should be determined by the doctor. Self-administration of Viferon gel in infants is not recommended.

Analogues

Instead of Viferon gel for herpes infection and ARVI, you can use the external remedy Infagel, which also contains interferon.

For more information about Viferon, see the following video.

Description of the dosage form

Release form, composition and packaging

Gel for topical application in the form of a homogeneous, opaque, gel-like mass of white color with a grayish tint.

Excipients:α-tocopherol acetate, methionine, benzoic acid, citric acid, sodium tetraborate, sodium chloride, human serum albumin, gel base (sodium carboxymethylcellulose, glycerin).

10 ml - aluminum tubes (1) - cardboard boxes.
10 ml - polystyrene jars (1) - cardboard boxes.

Ointment for external and local use yellow or yellowish-white, viscous, homogeneous, with a specific smell of lanolin.

Excipients: tocopherol acetate (20 mg), anhydrous lanolin, medical vaseline, peach oil, purified water.

6 g - aluminum tubes (1) - cardboard boxes.
12 g - aluminum tubes (1) - cardboard boxes.
12 g - polystyrene jars (1) - cardboard boxes.

Clinical and pharmacological group

Interferon. Immunomodulatory drug with antiviral action

pharmachologic effect

Human recombinant interferon alfa-2 preparation. It has pronounced antiviral, antiproliferative and immunomodulatory properties.

The complex composition of the gel and ointment Viferon causes a number of additional effects. In the presence of tocopherol acetate, the specific antiviral activity of interferon alfa-2 increases, its immunomodulatory effect increases (stimulation of the phagocytic function of neutrophils in the lesions). Tocopherol acetate, being a highly active antioxidant, has anti-inflammatory, membrane-stabilizing and regenerating properties.

When applied in the form of a gel, the gel base maintains the prolonged action of the drug, and the excipients support the stability of the specific activity and the proper microbiological purity of the drug.

Pharmacokinetics

With external and local application, systemic absorption of interferon is low.

Indications for the use of the drug

For gel

- prevention and treatment of children with frequent acute respiratory infections;

- prevention and treatment of recurrent stenosing laryngotracheobronchitis in children;

- treatment of chronic recurrent herpes infection of various localization in women.

For ointment

- treatment of viral (including those caused by the herpes virus) infections of the skin and mucous membranes.

Dosing regimen

Gel

For prevention of acute respiratory infections and recurrent stenosing laryngotracheobronchitis at children the gel is applied with a hard swab to the surface of the tonsils 3 times / day for 3 weeks. After 6 months, a second course is carried out similarly. Prevention of these diseases is recommended 2 times a year in spring and autumn.

For treatment ARI and recurrent stenosing laryngotracheobronchitis at children the gel is applied with a hard swab on the surface of the tonsils 5 times / day for 5-7 days, then 3 times / day for 3 weeks.

At chronic recurrent herpetic infection of various localization in women treatment is started as early as possible from the onset of relapse, preferably during the period of precursors. The gel is applied to the affected surface from 3 to 7 times / day for 10 days. If necessary, the duration of the course is increased to 10 days. The number of repeated courses is not limited.

When Viferon gel is applied to the affected area, a thin film is formed after 30-40 minutes, on which you can continue to apply the drug. If desired, the film can be peeled off or washed off with water. If it is necessary to apply the gel to the affected surface of the mucous membrane, it should first be dried with a gauze swab.

Ointment

At treatment of viral (including those caused by the herpes virus) infections of the skin and mucous membranes the ointment is applied in a thin layer on the lesions 3-4 times / day and gently rubbed, the duration of treatment is 5-7 days. It is recommended to start treatment immediately when the first signs of skin and mucous membrane lesions (itching, burning, redness) appear. When treating recurrent herpes, it is preferable to start treatment in the prodromal period or at the very beginning of the appearance of signs of relapse.

Side effect

When using the gel in some cases - an allergic reaction at the site of application (the use of the drug should be discontinued).

When applying the ointment in accordance with the recommended dosing regimen, no side effects were observed.

Contraindications to the use of the drug

- Hypersensitivity to the components of the drug.

The use of the drug during pregnancy and lactation

Since the systemic absorption of interferon is low with external and local use, and the drug has an effect only in the lesion, it is possible to use the drug Viferon in the form of an ointment during pregnancy and lactation (breastfeeding).

special instructions

There are no age restrictions for the use of the drug in the form of a gel according to indications and in recommended doses.

Overdose

Data on an overdose of the drug Viferon is not provided.

drug interaction

The use of Viferon in the form of an ointment is permissible against the background of therapy with other drugs.

Viferon in the form of an ointment is compatible and goes well with all drugs used in the treatment of viral (including herpetic) diseases of the skin and mucous membranes.

Terms of dispensing from pharmacies

The drug is dispensed by prescription.

Terms and conditions of storage

The drug should be stored and transported in accordance with SP 3.3.2.12.48-03 at a temperature of 2° to 8°C. The ointment should be stored in a place protected from light. The shelf life of the drug in the form of a gel and ointment is 1 year.

Not suitable for use drug with broken package integrity, labeling, changed color, improper storage.

The opened package of Viferon gel should be stored in the refrigerator for no more than 10 days, Viferon ointment - no more than 14 days.

The drug should be stored out of the reach of children.